News | May 23, 2023
Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The Group will continue to make proactive investments of its management resources in the life science business
Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Glenmark is the first company in India to market the innovative FDC of Indacaterol
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Subscribe To Our Newsletter & Stay Updated
